Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
doi: 10.3389/fphar.2022.850813 Received 19 January 2022 Accepted 25 February 2022 Published 18 March 2022 Volume 13 - 2022 Edited by Gokhan Zengin, Selcuk University, Turkey Reviewed by Ulrike Lindequist, University of Greifswald, Germany Emanuel Vamanu, University of Agricultural Sciences and Veterinary Medicine, Romania Updates Copyright 2022 Fu and Shen
These results highlight an urgent need for clinical trials to test whether GLP-1 medications can actually enhance cancer survival, particularly among patients with obesity-related cancers
At The Respire Institute , were watching this development closely
Why this matters for protocol design Three mechanistic features drive dosing decisions in research designs
US$ 28.78
US$ 29.04
US$ 23.21
US$ 29.13
US$ 27.78
US$ 20.98
US$ 28.48
US$ 19.99
US$ 26.16
US$ 21.42
US$ 23.10
US$ 20.45
US$ 25.97
US$ 23.03
US$ 23.32
